4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-013470
EVP, Chief Financial Officer sold 577 shares at $18.78 ($10,836)
- EVP, Chief Financial Officer acquired 1,353 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-02-23 | Option exercise | +1,353 | 4,695 | D | ||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-02-24 | Sale | −577 | $18.78 | $10,836 | 4,118 | D |
| Derivatives | |||||||
| Schneyer Mark C. EVP, Chief Financial Officer | 2023-02-23 | Option exercise · Restricted Stock Units | −1,353 | 2,706 | D | ||
| Open-market sales · 577 sh · avg $18.78 · $10,836 | |||||||
Loading xslF345X03/doc4.xml…